Question
In January, 2022, due to Covid cases has been severely raised, UEL, contacted Pfizer-cne of the world's premier biopharmaceutical companies to buy the patent rights
In January, 2022, due to Covid cases has been severely raised, UEL, contacted Pfizer-cne of the world's premier biopharmaceutical companies to buy the patent rights for Pfizer-BioTech COVID-19 Vaccine production. Pfizer agreed to transfer with total costs of USD1,000,000 on credit, payment would be settled in February 2023. The patent rights expires after 10 years according to legal clause, however, based on optimistic anticipation on herd immunity, UEL oy expects to make use of this Vaccine patent for 5 years from now and then dispose of this patens rights. Exchange rate at the date of transactions was USD 1 -CHF 0.89, at year end was USD 1-CHF 0,99. Amortisation expenses would move to Admin expenses
Require: book entry
Step by Step Solution
There are 3 Steps involved in it
Step: 1
![blur-text-image](https://dsd5zvtm8ll6.cloudfront.net/includes/images/document_product_info/blur-text-image.webp)
Get Instant Access with AI-Powered Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
![blur-text-image](https://dsd5zvtm8ll6.cloudfront.net/includes/images/document_product_info/blur-subtext-image.webp)
Step: 3
![blur-text-image](https://dsd5zvtm8ll6.cloudfront.net/includes/images/document_product_info/blur-subtext-image.webp)
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started